National MS Society. MS symptoms 2020. https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms.
Accessed 24 Sept 2020.
Parker LS, Topcu G, De Boos D, das Nair R. The notion of “invisibility” in people’s experiences of the symptoms of multiple sclerosis: a systematic meta-synthesis. Disabil Rehabil. 2020:1–15.
White CP, White MB, Russell CS. Invisible and visible symptoms of multiple sclerosis: which are more predictive of health distress? J Neurosci Nurs. 2008;40(2):85–95 (102).
Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms—a narrative review. Neurol Ther. 2020. https://doi.org/10.1007/s40120-021-00239-2.
American Academy of Neurology, Members MSWG. Multiple sclerosis quality measurement set: American Academy of Neurology; 2015. https://www.aan.com/siteassets/home-page/policy-and-guidelines/quality/quality-measures/14msmeasureset_pg.pdf. Accessed 23 Sept 2020.
Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Kesselring J, et al. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: a combined perspective from the MS in the 21st century Steering Group. Mult Scler Relat Disord. 2018;19:153–60.
Murphy R, O’Donoghue S, Counihan T, McDonald C, Calabresi PA, Ahmed MA, et al. Neuropsychiatric syndromes of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2017;88(8):697–708.
Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric symptoms of multiple sclerosis: state of the art. Psychiatry Investig. 2019;16(12):877–88.
Jun-O’Connell AH, Butala A, Morales IB, Henninger N, Deligiannidis KM, Byatt N, et al. The prevalence of bipolar disorders and association with quality of life in a cohort of patients with multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2017;29(1):45–51.
Mitchell AJ, Benito-León J, González JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol. 2005;4(9):556–66.
Gill S, Santo J, Blair M, Morrow SA. Depressive symptoms are associated with more negative functional outcomes than anxiety symptoms in persons with multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2019;31(1):37–42.
McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, et al. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology. 2018;90(15):e1316–23.
Mohr DC, Hart SL, Fonareva I, Tasch ES. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler J. 2006;12(2):204–8.
Raissi A, Bulloch AGM, Fiest KM, McDonald K, Jetté N, Patten SB. Exploration of undertreatment and patterns of treatment of depression in multiple sclerosis. Int J MS Care. 2015;17(6):292–300.
Binns CC. Bridge over troubled waters. MS FOCUS Mag. 2020;13:2020.
Stojanov A, Malobabic M, Milosevic V, Stojanov J, Vojinovic S, Stanojevic G, et al. Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak. Mult Scler Relat Disord. 2020;45:102407.
Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A, et al. Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology. 2015;85(22):1972–9.
Ross A, Weigel M. What is the role of stress in multiple sclerosis? Couns Points. 2016;11(2):4–12.
Foley F, Sarnoff J. Taming stress in multiple sclerosis [Brochure]. 2016. Retreived from: National MS Society. https://www.nationalmssociety.org/NationalMSSociety/media/MSNationalFiles/Brochures/Brochure-Taming-Stress.pdf. Accessed 12 July 2020.
Mohr DC, Hart SL, Julian L, Cox D, Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ. 2004;328(7442):731.
Mohr DC, Pelletier D. A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun. 2006;20(1):27–36.
Briones-Buixassa L, Milà R, Ma Aragonès J, Bufill E, Olaya B, Arrufat FX. Stress and multiple sclerosis: a systematic review considering potential moderating and mediating factors and methods of assessing stress. Health Psychol Open. 2015;2(2):2055102915612271.
Burns MN, Nawacki E, Kwasny MJ, Pelletier D, Mohr DC. Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis? Psychol Med. 2014;44(2):349–59.
National MS Society. Emotional changes 2020. https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms/Emotional-Changes. Accessed 20 Aug 2020.
National MS Society. Depression 2020 [updated 2020]. https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms/Depression. Accessed 12 July 2020.
Fruehwald S, Loeffler-Stastka H, Eher R, Saletu B, Baumhackl U. Depression and quality of life in multiple sclerosis. Acta Neurol Scand. 2001;104(5):257–61.
D’Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil Rehabil. 2006;28(5):307–14.
Yalachkov Y, Soydas D, Bergmann J, Frisch S, Behrens M, Foerch C, et al. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Mult Scler Relat Disord. 2019;30:33–7.
Schmidt S, Jostingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: results of a cross-sectional study. Mult Scler Relat Disord. 2019;35:262–9.
Berrigan LI, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, et al. Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity. Neurology. 2016;86(15):1417–24.
Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331–41.
Hanna M, Strober LB. Anxiety and depression in multiple sclerosis (MS): antecedents, consequences, and differential impact on well-being and quality of life. Mult Scler Relat Disord. 2020;44:102261.
Pham T, Jetté N, Bulloch AGM, Burton JM, Wiebe S, Patten SB. The prevalence of anxiety and associated factors in persons with multiple sclerosis. Mult Scler Relat Disord. 2018;19:35–9.
Franco M. Anxiety Multiple Sclerosis Association of America 2014. https://www.mymsaa.org/ms-information/symptoms/anxiety/. Accessed 12 July 2020.
Brenner P, Burkill S, Jokinen J, Hillert J, Bahmanyar S, Montgomery S. Multiple sclerosis and risk of attempted and completed suicide—a cohort study. Eur J Neurol. 2016;23(8):1329–36.
Feinstein A, Pavisian B. Multiple sclerosis and suicide. Mult Scler. 2017;23(7):923–7.
Paparrigopoulos T, Ferentinos P, Kouzoupis A, Koutsis G, Papadimitriou GN. The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. Int Rev Psychiatry. 2010;22(1):14–21.
Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology. 2002;59(5):674–8.
O’Donnell ML, Agathos JA, Metcalf O, Gibson K, Lau W. Adjustment disorder: current developments and future directions. Int J Environ Res Public Health. 2019;16(14):2537.
Pérez LP, González RS, Lázaro EB. Treatment of mood disorders in multiple sclerosis. Curr Treat Options Neurol. 2015;17(1):323.
Meier U-C, Ramagopalan SV, Goldacre MJ, Goldacre R. Risk of schizophrenia and bipolar disorder in patients with multiple sclerosis: record-linkage studies. Front Psychiatry. 2020;11:662.
Cirino E. Adjustment Disorder healthline: healthline; 2019. https://www.healthline.com/health/adjustment-disorder. Accessed 12 July 2020.
Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB, et al. Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(2):174–81.
The National Institute of Mental Health. Bipolar Disorder: The National Institute of Mental Health; 2020. https://www.nimh.nih.gov/health/topics/bipolar-disorder/index.shtml#part_145404. Accessed 12 July 2020.
Satzer D, Bond DJ. Mania secondary to focal brain lesions: implications for understanding the functional neuroanatomy of bipolar disorder. Bipolar Disord. 2016;18(3):205–20.
Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler. 2015;21(3):305–17.
NHS. Psychosis 2019. https://www.nhs.uk/conditions/psychosis/symptoms/. Accessed 12 July 2020.
Dolce K. I found out the hard way which of my drugs interact badly with each other. Multiplesclerosis.net. 2020. Retrieved from: https://multiplesclerosis.net/living-with-ms/hard-way-drugs-interact/. Accessed 29 Sept 2020.
Boster A. Rare and unusual MS symptoms (I've seen in clinic); 2018.
Rossi S, Studer V, Motta C, Polidoro S, Perugini J, Macchiarulo G, et al. Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology. 2017;89(13):1338–47.
Moghadasi AN. “Disability Grief”: a patient’s allegorical expression of her disability. Iran J Neurol. 2019;18(4):190–1.
Janssens AC, van Doorn PA, de Boer JB, van der Meche FG, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand. 2003;108(6):389–95.
Binns C. Suicide and MS. MSFOCUS Mag. 2020;22:32.
Burtchell J, Fetty K, Miller K, Minden K, Kantor D. Two sides to every story: perspectives from four patients and a healthcare professional on multiple sclerosis disease progression. Neurol Ther. 2019;8(2):185–205.
Tintoré M, Alexander M, Costello K, Duddy M, Jones DE, Law N, et al. The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction. Patient Prefer Adher. 2017;11:33–45.
Spencer LA, Silverman AM, Cook JE. Adapting to multiple sclerosis stigma across the life span. Int J MS Care. 2019;21(5):227–34.
Irvine H, Davidson C, Hoy K, Lowe-Strong A. Psychosocial adjustment to multiple sclerosis: exploration of identity redefinition. Disabil Rehabil. 2009;31(8):599–606.
Bostwick JM, Pabbati C, Geske JR, McKean AJ. Suicide attempt as a risk factor for completed suicide: even more lethal than we knew. Am J Psychiatry. 2016;173(11):1094–100.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–44.
Pfizer. Patient Health Questionnaire (PHQ) screeners 2013. http://www.phqscreeners.com. Accessed 24 Aug 2020.
Beck AT, Steer RA, Brown G. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation; 1996.
Pearson. Beck Depression Inventory-II (pricing and ordering) 2020. https://www.pearsonassessments.com/store/usassessments/en/Store/Professional-Assessments/Personality-%26-Biopsychosocial/Beck-Depression-Inventory-II/p/100000159.html?tab=pricing-ordering. Accessed 24 Aug 2020.
Terrill AL, Hartoonian N, Beier M, Salem R, Alschuler KN. The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis. Int J MS Care. 2015;17(2):49–56.
Litster B, Fiest KM, Patten SB, Fisk JD, Walker JR, Graff LA, et al. Screening tools for anxiety in people with multiple sclerosis: a systematic review. Int J MS Care. 2016;18(6):273–81.
Mapi Research Trust. Hospital Anxiety and Depression Scale (HADS) 2020. https://eprovide.mapi-trust.org/instruments/hospital-anxiety-and-depression-scale#need_this_questionnaire. Accessed 24 Aug 2020.
Lorenz L, Bachem RC, Maercker A. The adjustment disorder-new module 20 as a screening instrument: cluster analysis and cut-off values. Int J Occup Environ Med. 2016;7(4):215–20.
Einsle F, Köllner V, Dannemann S, Maercker A. Development and validation of a self-report for the assessment of adjustment disorders. Psychol Health Med. 2010;15(5):584–95.
Ben-Ezra M, Mahat-Shamir M, Lorenz L, Lavenda O, Maercker A. Screening of adjustment disorder: scale based on the ICD-11 and the adjustment disorder new module. J Psychiatr Res. 2018;103:91–6.
Lorenz L. Self-report for the assessment of adjustment disorder ADNM—20 questionnaire: University of Zurich; 2016. https://www.psychology.uzh.ch/dam/jcr:15220404-d1b2-4d9a-9661-f1709b4ca3f4/ADNM_20.pdf. Accessed 25 Aug 2020.
Hirschfeld RM. The Mood Disorder Questionnaire: a simple, patient-rated screening instrument for bipolar disorder. Prim Care Companion J Clin Psychiatry. 2002;4(1):9–11.
Phalen PL, Rouhakhtar PR, Millman ZB, Thompson E, DeVylder J, Mittal V, et al. Validity of a two-item screen for early psychosis. Psychiatry Res. 2018;270:861–8.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96.
Carver CS. You want to measure coping but your protocol’ too long: consider the brief cope. Int J Behav Med. 1997;4(1):92.
NovoPsych. Brief-COPE 2020. https://novopsych.com.au/assessments/brief-cope/. Accessed 24 Aug 2020.
Wagnild GM, Young HM. Development and psychometric evaluation of the resilience scale. J Nurs Meas. 1993;1(2):165–78.
Fletcher D, Sarkar M. Psychological resilience. Eur Psychol. 2013;18(1):12–23.
Nakazawa K, Noda T, Ichikura K, Okamoto T, Takahashi Y, Yamamura T, et al. Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2018;25:309–15.
Godman H. How resilience training can help people with MS. US News and World Report. 2017.
National MS Society. Resilience: addressing the challenges of MS. 2020. https://multiplesclerosis.net/living-with-ms/hard-way-drugs-interact/. Accessed 24 Aug 2020.
Barker AB, Lincoln NB, Hunt N, das Nair R, . Social identity in people with multiple sclerosis: an examination of family identity and mood. Int J MS Care. 2018;20(2):85–91.
Koelmel E, Hughes AJ, Alschuler KN, Ehde DM. Resilience mediates the longitudinal relationships between social support and mental health outcomes in multiple sclerosis. Arch Phys Med Rehabil. 2017;98(6):1139–48.
Ong S. How face masks affect our communication. BBC Future. 2020. https://www.bbc.com/future/article/20200609-how-face-masks-affect-our-communication. Accessed 24 Sept 2020.
Holland K. Online Multiple Sclerosis Support Groups: Healthline; 2018. https://www.healthline.com/health/multiple-sclerosis/support-groups. Accessed 24 Aug 2020.
Kantor D, Bright JR, Burtchell J. Perspectives from the patient and the healthcare professional in multiple sclerosis: social media and patient education. Neurol Ther. 2018;7(1):23–36.
National MS Society. Find support 2020. https://www.nationalmssociety.org/Resources-Support/Find-Support. Accessed 24 Aug 2020.
National MS Society. MSFriends 2020. https://www.nationalmssociety.org/Programs-and-Services/Programs/MSFriends. Accessed 17 Dec 2020.
MultipleSclerosis.net. Community 2020. https://www.multiplesclerosis.net/community/. Accessed 24 Aug 2020.
National MS Society. National Multiple Sclerosis Society Community [private Facebook group] 2020. https://www.facebook.com/groups/1119529838249750/. Accessed 24 Sept 2020.
Multiple Sclerosis Association of America. Multiple Sclerosis Association of America [community tab of organization Facebook page] 2020. https://www.facebook.com/msassociation/community/?ref=page_internal. Accessed 24 Sept 2020.
Multiple Sclerosis Foundation. Multiple Sclerosis Foundation Facebook Group 2020. https://www.facebook.com/groups/msfocus. Accessed 24 Aug 2020.
Multiple Sclerosis Foundation. Multiple Sclerosis Foundation [public Facebook group] 2020. https://www.facebook.com/groups/msfocus/. Accessed 24 Sept 2020.
Multiple Sclerosis Foundation. MS Focus Confidential [private Facebook group] 2020. https://www.facebook.com/groups/906460479752961/. Accessed 24 Sept 2020.
Lorefice L, Fenu G, Frau J, Coghe G, Marrosu MG, Cocco E. The burden of multiple sclerosis and patients’ coping strategies. BMJ Support Palliat Care. 2018;8(1):38–40.
Rintell DJ, Frankel D, Minden SL, Glanz BI. Patients’ perspectives on quality of mental health care for people with MS. Gen Hosp Psychiatry. 2012;34(6):604–10.
Sullivan A. The importance of interdisciplinary care in MS. In: Meglio M, editor. NeurologyLive; 2020. https://www.neurologylive.com/conferences/cmsc-2020/the-importance-of-interdisciplinary-care-in-ms. Accessed 12 July 2020.
Sullivan A. Science, art, and practice of behavioral medicine in MS: 2020 CMSC virtual annual meeting; 2020.
Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA. 1992;267(16):2221–6.
Strum J. Bonus: From the CMSC Meeting Day 1 [Internet]; 2019 May 29, 2019 [cited August 25, 2020]. Podcast. https://www.realtalkms.com/bonus-from-the-cmsc-meeting-day-1-5-29-2019/. Accessed 25 Aug 2020.
Methley A, Campbell S, Cheraghi-Sohi S, Chew-Graham C. Meeting the mental health needs of people with multiple sclerosis: a qualitative study of patients and professionals. Disabil Rehabil. 2017;39(11):1097–105.
Rensel MR, Hersch C, Moss B. General health and wellness in multiple sclerosis. Multiple sclerosis and related disorders: clinical guide to diagnosis, medical management, and rehabilitation. 2nd ed. New York: Springer Publishing Company; 2018. p. 235–52.
Rensel MR. General health and wellness in multiple sclerosis. Multiple sclerosis and related disorders: diagnosis, medical management, and rehabilitation. 1st ed. New York: Demos Medical Publishing, LLc.; 2013. p. 235–42.
Reynard AK, Sullivan AB, Rae-Grant A. A systematic review of stress-management interventions for multiple sclerosis patients. Int J MS Care. 2014;16(3):140–4.
Mohr DC, Lovera J, Brown T, Cohen B, Neylan T, Henry R, et al. A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology. 2012;79(5):412–9.
Cadden MH, Arnett PA, Tyry TM, Cook JE. Judgment hurts: the psychological consequences of experiencing stigma in multiple sclerosis. Soc Sci Med. 2018;208:158–64.
Robati Z, Shareh H. The effectiveness of cognitive-behavioral group therapy in anxiety and self-esteem in patients with multiple sclerosis. J Fundam Ment Health. 2018;20(6):405–16.
Hoseini Tabatabaei R, Bolghan-Abadi M. Effectiveness of solution-focused group therapy in generalized anxiety disorder in patients with multiple sclerosis. Zahedan J Res Med Sci. 2020;22(2):e69355.
Giovannetti AM, Quintas R, Tramacere I, Giordano A, Confalonieri P, Messmer Uccelli M, et al. A resilience group training program for people with multiple sclerosis: results of a pilot single-blind randomized controlled trial and nested qualitative study. PLoS ONE. 2020;15(4):e0231380.
Abbatemarco JR, Cohen JA, Udeh BL, Rensel MR, editors. Improved multiple sclerosis management using shared medical appointments—a single center experience. Madison: ACTRIMS; 2020.
Borghi M, Bonino S, Graziano F, Calandri E. Exploring change in a group-based psychological intervention for multiple sclerosis patients. Disabil Rehabil. 2018;40(14):1671–8.
Russell RD, Black LJ, Pham NM, Begley A. The effectiveness of emotional wellness programs on mental health outcomes for adults with multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. 2020;44:102171.
Simpson R, Simpson S, Ramparsad N, Lawrence M, Booth J, Mercer SW. Mindfulness-based interventions for mental well-being among people with multiple sclerosis: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry. 2019;90(9):1051–8.
Impellizzeri F, Leonardi S, Latella D, Maggio MG, Foti Cuzzola M, Russo M, et al. An integrative cognitive rehabilitation using neurologic music therapy in multiple sclerosis: a pilot study. Medicine (Baltimore). 2020;99(4):e18866.
Motl RW, Mowry EM, Ehde DM, LaRocca NG, Smith KE, Costello K, et al. Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities. Mult Scler. 2018;24(3):262–7.
Dunn M, Bhargava P, Kalb R. Your patients with multiple sclerosis have set wellness as a high priority-and the national multiple sclerosis society is responding. US Neurol. 2015;11(2):80–6.
Alphonsus KB, Su Y, D’Arcy C. The effect of exercise, yoga and physiotherapy on the quality of life of people with multiple sclerosis: systematic review and meta-analysis. Complement Ther Med. 2019;43:188–95.
Donia SA, Allison DJ, Gammage KL, Ditor DS. The effects of acute aerobic exercise on mood and inflammation in individuals with multiple sclerosis and incomplete spinal cord injury. NeuroRehabilitation. 2019;45(1):117–24.
Hasanpour DA. Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: a randomized trial. J Sports Med Phys Fit. 2016;56(11):1417–22.
Crouch TA, Verdi EK, Erickson TM. Gratitude is positively associated with quality of life in multiple sclerosis. Rehabil Psychol. 2020;65(3):231–8.
Senders A, Borgatti A, Hanes D, Shinto L. Association between pain and mindfulness in multiple sclerosis: a cross-sectional survey. Int J MS Care. 2018;20(1):28–34.
Simpson R, Simpson S, Ramparsad N, Lawrence M, Booth J, Mercer SW. Effects of Mindfulness-based interventions on physical symptoms in people with multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. 2020;38:101493.
Gandy M, Karin E, McDonald S, Meares S, Scott AJ, Titov N, et al. A feasibility trial of an internet-delivered psychological intervention to manage mental health and functional outcomes in neurological disorders. J Psychosom Res. 2020;136:110173.
Sullivan AB, Kane A, Roth AJ, Davis BE, Drerup ML, Heinberg LJ. The COVID-19 crisis: a mental health perspective and response using telemedicine. J Patient Exp. 2020;7:2374373520922747.
Grubic Kezele T, Babic M, Stimac D. Exploring the feasibility of a mild and short 4-week combined upper limb and breathing exercise program as a possible home base program to decrease fatigue and improve quality of life in ambulatory and non-ambulatory multiple sclerosis individuals. Neurol Sci. 2019;40(4):733–43.
Lukmanji S, Pham T, Blaikie L, Clark C, Jetté N, Wiebe S, et al. Online tools for individuals with depression and neurologic conditions: a scoping review. Neurol Clin Pract. 2017;7(4):344–53.
Morin A. The 7 Best Mental Health Apps of 2020: verywellmind; 2020. https://www.verywellmind.com/best-mental-health-apps-4692902. Accessed 25 Sept 2020.
Olayiwola JN, Magaña C, Harmon A, Nair S, Esposito E, Harsh C, et al. Telehealth as a bright spot of the COVID-19 pandemic: recommendations from the virtual frontlines (“Frontweb”). JMIR Public Health Surveill. 2020;6(2):e19045.
Henry TA. COVID-19 makes telemedicine mainstream. Will it stay that way? AMA. 2020. https://www.ama-assn.org/practice-management/digital/covid-19-makes-telemedicine-mainstream-will-it-stay-way. Accessed 24 Sept 2020.
Overcoming Multiple Sclerosis. Overcoming multiple sclerosis 2020. https://overcomingms.org/. Accessed 7 Aug 2020.
MyLife. Find your quiet place with MyLife 2020. https://my.life/. Accessed 24 Sept 2020.
Headspace. Headspace 2020. https://www.headspace.com/.
Moodfit. Moodfit: fitness for your mental health 2020. https://www.getmoodfit.com/.
Society NM. Happy the App 2020. https://www.nationalmssociety.org/Resources-Support/Find-Support/Happy-the-App.
Happify Health. About us 2020. https://happify.com/health/about/. Accessed 24 Sept 2020.
Marques LJ. Partnership aims for FDA-approved app that aids mental health in MS, Sanofi announces. Mult Scler News Today. 2019;23:2019.